Ascendiant Capital Maintains Buy on Cingulate, Lowers Price Target to $44

Benzinga Newsdesk www.benzinga.com Negative 64.5%

Neg 64.5% Neu 0% Pos 0%

Ascendiant Capital analyst Edward Woo maintains Cingulate (NASDAQ:CING) with a Buy and lowers the price target from $52 to $44.